SCHEMBL7928856

SCHEMBL7928856

COc1cccc(-c2ccc3ccccc3c2Oc2ccc(N)cc2)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.51
ADORA2A P29274 2/20 0.44
ADORA1 P30542 1/20 0.43
CYP1A2 P05177 6/20 0.43
CYP1A1 P04798 3/20 0.43
CYP1B1 Q16678 3/20 0.43
KDM1A O60341 1/20 0.43
CYP3A4 P08684 4/20 0.42
CYP2C9 P11712 3/20 0.42
CYP2B6 P20813 3/20 0.42
CYP2D6 P10635 2/20 0.42
CYP2C19 P33261 2/20 0.42
CYP11B1 P15538 1/20 0.42
CYP11B2 P19099 1/20 0.42
BRD4 O60885 1/20 0.42
GPR84 Q9NQS5 1/20 0.42
CYP2A6 P11509 2/20 0.41
CYP2E1 P05181 1/20 0.41
CYP2C8 P10632 1/20 0.41
CYP4B1 P13584 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7940249 0.91 SMN1; SMN2 (0.52) SMN1; SMN2ADORA2AADORA1CYP1A2CYP1A1
SCHEMBL6050235 0.88 MIF (0.46) ADORA2AADORA1CYP1A2CYP1A1CYP1B1
SCHEMBL6050365 0.84 CYP1A2 (0.43) CYP1A2CYP1A1CYP1B1CYP3A4CYP2C9
SCHEMBL7937975 0.84 MEN1 (0.47) SMN1; SMN2ADORA2AADORA1KDM1AALDH1A1
SCHEMBL7937717 0.82 ABCG2 (0.49) SMN1; SMN2CYP1A2CYP1A1CYP1B1BRD4
SCHEMBL7937708 0.82 SMN1; SMN2 (0.45) SMN1; SMN2CYP1A2CYP1A1CYP1B1CYP3A4
SCHEMBL7928912 0.81 ABCG2 (0.48) SMN1; SMN2CYP1A2KDM1ACYP3A4CYP2C9
SCHEMBL7935041 0.81 ADORA2A (0.45) ADORA2AADORA1CYP1A2KDM1ACYP3A4
SCHEMBL8500385 0.81 TDP1 (0.47) CYP1A2CYP1A1CYP1B1BRD4GPR84
SCHEMBL8500390 0.80 AKR1C3 (0.58) CYP1A2CYP2C19GPR84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0835868-B1 2-Aryl-3-aminoaryloxynaphthyl compounds, intermediates, compositions and methods LILLY CO ELI (US) 2001-08-29 EP disclosed
US-5929090-A NOVEL COMPOUNDS FOR TREATING ESTROGEN DEPRIVATION CAUSED BY MENOPAUSE OR OVARIECTOMY; TREATING OSTEOPOROSIS, CARDIOVASCULAR DISEASES, AND ENDOMETRIOSIS ELI LILLY AND COMPANY (US) 1999-07-27 US disclosed
EP-0835868-A1 2-Aryl-3-aminoaryloxynaphthyl compounds, intermediates, compositions and methods ELI LILLY AND COMPANY (US) 1998-04-15 EP disclosed